Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 01, 2022
Jan. 01, 2022
Current assets:    
Cash and cash equivalents $ 36,813 $ 28,540
Restricted cash 33 41
Accounts receivable, net of allowance for credit losses of $1,122 and $1,212 131,649 134,561
Inventories, net 179,718 165,629
Income taxes receivable 6,517 2,762
Other current assets 19,543 20,101
Total current assets 374,273 351,634
Property, plant and equipment, net 171,323 174,210
Deferred income taxes 6,008 2,934
Goodwill 447,140 459,936
Other intangible assets, net 396,528 412,759
Other assets 24,295 13,873
Total assets 1,419,567 1,415,346
Current liabilities:    
Accounts payable 64,921 85,301
Accrued compensation and benefits 19,004 28,595
Other accrued expenses and current liabilities 30,890 28,254
Current portion of long-term non-revolving debt, net 18,897 18,125
Dividends payable 2,930 2,917
Income taxes payable 7,489 6,328
Total current liabilities 144,131 169,520
Revolving line of credit 267,693 242,312
Long-term non-revolving debt, net 169,332 183,897
Deferred income taxes 57,042 71,836
Other noncurrent liabilities 29,932 38,818
Total liabilities 668,130 706,383
Commitments and contingencies
Shareholders' equity:    
Preferred stock, par value $0.001, 2,000 shares authorized, no shares issued or outstanding 0 0
Common stock, par value $0.001, 100,000 shares authorized, 32,544 and 32,407 shares issued and outstanding 33 32
Capital in excess of par value 401,549 394,641
Retained earnings 435,392 363,279
Accumulated other comprehensive loss (85,537) (48,989)
Total shareholders' equity 751,437 708,963
Total liabilities and shareholders' equity $ 1,419,567 $ 1,415,346